Invitro Research Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.22 M
as on 16-11-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.04 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.50 M
as on 16-11-2024
- Revenue 28.38%
(FY 2023)
- Profit -59.05%
(FY 2023)
- Ebitda -19.30%
(FY 2023)
- Net Worth 224.85%
(FY 2023)
- Total Assets 38.32%
(FY 2023)
About Invitro Research Solutions
The Corporate was formerly known as Biostec Research Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹1.04 Cr. The company has closed loans amounting to ₹7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Subbaiah Devaiah and Umesh Bisile serve as directors at the Company.
- CIN/LLPIN
U74999KA2016PTC095072
- Company No.
095072
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Invitro Research Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbaiah Devaiah  | Whole-Time Director | 18-Jul-2016 | Current |
| Umesh Bisile | Whole-Time Director | 26-Feb-2021 | Current |
Financial Performance of Invitro Research Solutions.
Invitro Research Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.38% increase. The company also saw a substantial fall in profitability, with a 59.05% decrease in profit. The company's net worth Soared by an impressive increase of 224.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invitro Research Solutions?
In 2023, Invitro Research Solutions had a promoter holding of 37.00% and a public holding of 63.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biostec Data Safety Services Private LimitedActive 2 years 5 monthsSubbaiah Devaiah and Umesh Bisile are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Dec 2023 | ₹7.50 M | Open |
Others Creation Date: 25 Feb 2023 | ₹2.85 M | Open |
Others Creation Date: 13 Sep 2021 | ₹7.50 M | Satisfied |
How Many Employees Work at Invitro Research Solutions?
Unlock and access historical data on people associated with Invitro Research Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invitro Research Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invitro Research Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
